1.
Plecka P. Non-pegylated liposomal doxorubicin plus capecitabine as first-line treatment in metastatic breast cancer. OncoReview [Internet]. 2016Oct.25 [cited 2025Jun.27];6(4(24):193-8. Available from: https://www.journalsmededu.pl/index.php/OncoReview/article/view/500